Whitehouse Station-based global healthcare provider Merck announced Thursday the appointment of Robert M. Davis, 47, as its new executive vice president and chief financial officer, effective April 23, 2014.According to the announcement, Davis will oversee corporate strategy and business development. He will succeed Peter N. Kellogg, 58.
“Rob is an accomplished executive with significant financial and operational expertise, including as a CFO, and will be an exceptional addition to our team,” said Kenneth C. Frazier, chairman and chief executive officer, Merck. “Rob’s broad, global business and healthcare experience, which encompasses commercial, R&D, quality, regulatory, manufacturing and supply chain, will be an asset to us in implementing a significantly streamlined, more flexible cost structure and operating model, while enabling us to focus on our highest potential growth opportunities.”
ALSO ON NJBIZ:
Most-read March 26: NJBIZ Health Care Power 50 (slideshow)
Toys ‘R’ Us cuts 600 jobs
Small business owners lash out at Christie over Stronger NJ grant comments